RAPH — Raphael Pharmaceutical Balance Sheet
0.000.00%
- $4.35m
- $4.60m
Annual balance sheet for Raphael Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.105 | 0.153 | 0.288 | 0.23 | 0.019 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.557 | 0.422 | 0.331 | 0.237 | 0.025 |
Net Property, Plant And Equipment | — | — | 0.002 | 0.002 | 0.002 |
Net Intangible Assets | |||||
Total Assets | 0.566 | 0.422 | 0.333 | 0.239 | 0.027 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.763 | 0.294 | 0.227 | 0.132 | 0.769 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.763 | 0.294 | 0.227 | 0.132 | 0.769 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.197 | 0.128 | 0.106 | 0.107 | -0.742 |
Total Liabilities & Shareholders' Equity | 0.566 | 0.422 | 0.333 | 0.239 | 0.027 |
Total Common Shares Outstanding |